Rock Creek has developed this website content to help physicians and allied health care professionals review both the research that exists and which is being conducted on Anatabloc® and inflammation. When you log into this area you will be able to review summaries of each of the 23 premarket studies that were conducted to explore both toxicity and abuse potential for anatabine, the active dietary ingredient that is in Anatabloc® as well as our first product, CigRx®. We also have assembled summaries and illustrations of the cellular and animal research conducted by the Roskamp Institute for your review.

We have restricted access to this area of the website to licensed healthcare professionals because we believe that this content should be evaluated by those who have education and training in life sciences. We also do not want to mislead or confuse individual consumers who are interested in using Anatabloc® by presenting materials that contain technical scientific language.

Health Care Professional Access


I certify that I am a licensed healthcare provider and have read the Terms of Use.





Are you a health care professional interested in
learning more about Anatabloc®? Contact us to get access